• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大隐静脉作为胸廓内动脉的复合移植物。

Saphenous vein as a composite graft from the internal thoracic artery.

作者信息

Hwang Ho Young, Kim Ki-Bong

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Korea.

出版信息

Ann Cardiothorac Surg. 2018 Sep;7(5):686-689. doi: 10.21037/acs.2018.06.08.

DOI:10.21037/acs.2018.06.08
PMID:30505754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6219952/
Abstract

The saphenous vein (SV) has been used as an aortocoronary bypass graft for coronary artery bypass grafting (CABG) for the past 50 years. However, CABG using the aortocoronary SV has shown disadvantages of lower long-term graft patency rates and subsequently worse clinical outcomes, compared with CABG using the internal thoracic artery (ITA). The advantages of CABG using the ITA prompted interest in total arterial revascularization, using the bilateral ITAs and other arterial conduits as composite graft configurations in patients exhibiting multi-vessel disease. Total arterial revascularization using a Y- or T-composite graft based on the ITA increases the length of the arterial graft and allows the extensive use of arterial conduits to revascularize both the left and right coronary territories. Further, it has demonstrated favorable outcomes in terms of angiographic patency rates, myocardial perfusion and thickening by single photon emission computed tomography, and long-term clinical outcomes. However, previous studies describing the use of the SV conduit as a composite graft have produced conflicting results. In this article, a recent surgical strategy of using the SV as part of a composite graft based on the left ITA will be discussed.

摘要

在过去50年里,大隐静脉(SV)一直被用作冠状动脉旁路移植术(CABG)的主动脉冠状动脉旁路移植血管。然而,与使用胸廓内动脉(ITA)的CABG相比,使用主动脉冠状动脉大隐静脉的CABG显示出长期移植血管通畅率较低以及随后临床结果较差的缺点。使用ITA进行CABG的优势引发了人们对全动脉血运重建的兴趣,即在患有多支血管疾病的患者中,将双侧ITA和其他动脉管道用作复合移植结构。基于ITA使用Y型或T型复合移植物进行全动脉血运重建可增加动脉移植物的长度,并允许广泛使用动脉管道对左、右冠状动脉区域进行血运重建。此外,在血管造影通畅率、心肌灌注以及单光子发射计算机断层扫描显示的心肌增厚情况和长期临床结果方面,它都显示出良好的效果。然而,先前描述将大隐静脉管道用作复合移植物的研究结果相互矛盾。在本文中,将讨论一种最近的手术策略,即将大隐静脉用作基于左ITA的复合移植物的一部分。

相似文献

1
Saphenous vein as a composite graft from the internal thoracic artery.大隐静脉作为胸廓内动脉的复合移植物。
Ann Cardiothorac Surg. 2018 Sep;7(5):686-689. doi: 10.21037/acs.2018.06.08.
2
Patency rate of the internal thoracic artery to the left anterior descending artery bypass is reduced by competitive flow from the concomitant saphenous vein graft in the left coronary artery.来自左冠状动脉中同时存在的大隐静脉移植物的竞争性血流会降低胸廓内动脉至左前降支动脉搭桥的通畅率。
Eur J Cardiothorac Surg. 2008 Oct;34(4):833-8. doi: 10.1016/j.ejcts.2008.07.011. Epub 2008 Aug 23.
3
A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year angiographic results and mid-term clinical outcomes.大隐静脉与右胸廓内动脉作为Y形复合移植物的随机对照试验(SAVE RITA):1年血管造影结果及中期临床结局
J Thorac Cardiovasc Surg. 2014 Sep;148(3):901-7; discussion 907-8. doi: 10.1016/j.jtcvs.2014.03.057. Epub 2014 May 16.
4
Saphenous vein: advances.隐静脉:进展
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):251-257. doi: 10.1007/s12055-018-0753-9. Epub 2018 Oct 29.
5
Morphologic changes of the saphenous vein Y-composite graft based on the left internal thoracic artery: 1-year intravascular ultrasound study.基于左内乳动脉的隐静脉 Y 型复合移植物的形态学变化:1 年的血管内超声研究。
J Thorac Cardiovasc Surg. 2015 Feb;149(2):487-93. doi: 10.1016/j.jtcvs.2014.08.056. Epub 2014 Sep 16.
6
Reusing the patent internal mammary artery as a conduit in redo coronary artery bypass surgery.在再次冠状动脉搭桥手术中复用胸廓内动脉作为血管桥。
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):346-50. doi: 10.1093/icvts/ivv338. Epub 2015 Dec 15.
7
Endothelial Shear Stress of the Saphenous Vein Composite Graft Based on the Internal Thoracic Artery.基于内乳动脉的隐静脉复合移植物的内皮切应力。
Ann Thorac Surg. 2018 Feb;105(2):564-571. doi: 10.1016/j.athoracsur.2017.08.025. Epub 2017 Nov 23.
8
Lower versus upper leg saphenous vein composite grafts based on the left internal thoracic artery: A randomized study.基于左内乳动脉的下肢与小腿隐静脉复合移植物:一项随机研究。
J Thorac Cardiovasc Surg. 2018 Sep;156(3):986-994.e2. doi: 10.1016/j.jtcvs.2018.03.148. Epub 2018 Apr 11.
9
Bilateral internal thoracic artery grafting: Does graft configuration affect outcome?双侧胸廓内动脉移植:移植结构会影响结果吗?
J Thorac Cardiovasc Surg. 2016 Jul;152(1):120-7. doi: 10.1016/j.jtcvs.2016.03.022. Epub 2016 Mar 12.
10
Comparison of perfusion and thickening between vein and right internal thoracic artery composite grafts from a randomized trial substudy.从一项随机试验的子研究比较静脉和右内乳动脉复合移植物的灌注和增厚情况。
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1187-94. doi: 10.1016/j.jtcvs.2015.08.009. Epub 2015 Aug 8.

引用本文的文献

1
The impact of perivascular tissue preservation on 5-year patency of saphenous vein composite grafts.血管周围组织保留对大隐静脉复合移植物5年通畅率的影响。
Interdiscip Cardiovasc Thorac Surg. 2024 May 2;38(5). doi: 10.1093/icvts/ivae069.
2
Graft Patency of No-Touch Saphenous Veins Used as Aortocoronary Bypass Grafts.用作主动脉冠状动脉旁路移植术的非接触式大隐静脉的移植通畅情况。
J Chest Surg. 2023 Sep 5;56(5):313-321. doi: 10.5090/jcs.23.027. Epub 2023 Aug 14.
3
Anterolateral territory coronary artery bypass grafting strategies: a non-inferiority randomized clinical trial: the AMI-PONT trial.前外侧区域冠状动脉旁路移植术策略的非劣效性随机临床试验:AMI-PONT 试验。
Eur J Cardiothorac Surg. 2023 Apr 3;63(4). doi: 10.1093/ejcts/ezad060.
4
The Anaortic Technique with Bilateral Internal Thoracic Artery Grafting - Filling the Gap in Coronary Artery Bypass Surgery.非体外循环下双侧内乳动脉搭桥术——填补冠状动脉旁路移植术的空白。
Braz J Cardiovasc Surg. 2021 Jun 1;36(3):397-405. doi: 10.21470/1678-9741-2020-0451.
5
Pathophysiology of saphenous vein valves in coronary artery bypass with composite arteriovenous grafts.冠状动脉搭桥术中采用动静脉复合移植物时隐静脉瓣膜的病理生理学
Ann Cardiothorac Surg. 2019 Mar;8(2):300-301. doi: 10.21037/acs.2019.02.06.

本文引用的文献

1
Intraoperative Analysis of Flow Dynamics in Arteriovenous Composite Y Grafts.动静脉复合Y型移植物血流动力学的术中分析
Braz J Cardiovasc Surg. 2016 Sep-Oct;31(5):351-357. doi: 10.5935/1678-9741.20160053.
2
Equivalency of Saphenous Vein and Arterial Composite Grafts: 5-Year Angiography and Midterm Clinical Follow-Up.大隐静脉与动脉复合移植物的等效性:5年血管造影及中期临床随访
Ann Thorac Surg. 2016 Aug;102(2):580-8. doi: 10.1016/j.athoracsur.2016.02.017. Epub 2016 May 19.
3
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.冠状动脉旁路移植术中隐静脉移植物外部支架置入的随机试验
Ann Thorac Surg. 2015 Jun;99(6):2039-45. doi: 10.1016/j.athoracsur.2015.01.060. Epub 2015 Apr 15.
4
Complete Revascularization of the Three-Vessel Territories Using a Left Internal Thoracic Artery Composite Graft.使用左胸廓内动脉复合移植物实现三支血管区域的完全血运重建。
Ann Thorac Surg. 2015 Jul;100(1):59-66. doi: 10.1016/j.athoracsur.2015.01.068. Epub 2015 Apr 15.
5
A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year angiographic results and mid-term clinical outcomes.大隐静脉与右胸廓内动脉作为Y形复合移植物的随机对照试验(SAVE RITA):1年血管造影结果及中期临床结局
J Thorac Cardiovasc Surg. 2014 Sep;148(3):901-7; discussion 907-8. doi: 10.1016/j.jtcvs.2014.03.057. Epub 2014 May 16.
6
Equivalency of right internal thoracic artery and right gastroepiploic artery composite grafts: five-year outcomes.右内乳动脉与胃网膜右动脉复合移植物等效性:5 年结果。
Ann Thorac Surg. 2013 Dec;96(6):2061-8. doi: 10.1016/j.athoracsur.2013.07.003. Epub 2013 Sep 12.
7
Bilateral internal thoracic artery in situ versus y-composite graftings: five-year angiographic patency and long-term clinical outcomes.原位双侧胸廓内动脉与 Y 型复合移植物:5 年血管造影通畅率和长期临床结果。
Ann Thorac Surg. 2011 Aug;92(2):579-85; discussion 585-6. doi: 10.1016/j.athoracsur.2011.03.145.
8
Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries.复合 Y 型移植物的分流量储备与隐静脉或右内乳动脉的比较。
J Thorac Cardiovasc Surg. 2010 Sep;140(3):639-45. doi: 10.1016/j.jtcvs.2009.11.013. Epub 2010 Feb 18.
9
Improved myocardial perfusion and thickening after off-pump revascularization: 5-year follow-up.非体外循环冠状动脉搭桥术后心肌灌注及增厚情况改善:5年随访
Ann Thorac Surg. 2009 Nov;88(5):1419-25. doi: 10.1016/j.athoracsur.2009.07.004.
10
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.E2F转录因子诱饵edifoligide预防冠状动脉旁路移植术后静脉移植物失败的疗效和安全性:PREVENT IV随机对照试验
JAMA. 2005 Nov 16;294(19):2446-54. doi: 10.1001/jama.294.19.2446.